InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Garipalli Vivek, Director. Insider active across 1 companies, notably Clover Health Investments, CORP. /de. In total, 4 reports have been published. Total volume traded: €1.6m. The latest transaction was filed on 7 August 2025 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations4 total
US$796,119415,000 shares@ US$1.91840.065% mcap100.0% of flow
Class A Common Stock
SEC:0001801170-25-000207·
Ideal exit: 4 May 2026 (T+270)
€796,119415,000 shares@ €1.91840.065% mcap50.0% of flow
Class A Common Stock
SEC:0001801170-25-000207:0·
Ideal exit: 4 May 2026 (T+270)
3,342,698 shares
Class B Common Stock
SEC:0001628280-22-000730·
3,342,698 shares
Class B Common Stock
SEC:0001628280-22-000730:0·
4 of 4 declarations
About Garipalli Vivek
Vivek Garipalli is a Director and Chief Executive Officer of Clover Health Investments, Corp. /DE. He leads the company with a focus on strategy and growth. His experience in the health sector is an asset for developing innovative solutions.
